Semaglutide reduces cardiovascular events in adults who are overweight by 20%, study finds Trial results show fewer deaths from cardiovascular events, as well as non-fatal heart attacks and strokes, in patients who received semaglutide versus those who received placebo.…
Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
UK regulator seizes 369 potentially fake weight loss pens following reports of hospitalisations The Medicines and Healthcare products Regulatory Agency said the public should consult a healthcare professional qualified to provide semaglutide and liraglutide via prescription.…
‘Limited’ supply of weight loss drug semaglutide launched in UK Manufacturer Novo Nordisk said it will monitor demand and work with regulators to ensure Wegovy is accessible to eligible patients.…
NHS weight-loss drugs could be prescribed via apps, says NICE draft guidance Some of the apps that could be made available include the ability to prescribe weight-loss management medication to eligible patients.…
GPs to prescribe weight loss injections under £40m pilot scheme The GP-prescribing pilot is aimed to explore how drugs can be made available to more people by expanding specialist weight management services outside hospital settings.…
Weight-loss drug semaglutide recommended for use in teenagers in Europe Wegovy has been recommended for use in adolescents aged 12 years and over with obesity and a body weight above 60kg.…
Private pharmacy semaglutide services must provide long-term support, say experts Exclusive: Online pharmacies and large multiples are already signing patients up to receive information about their new private semaglutide services as soon as the drug becomes available in the UK, which is expected to be soon.…
Should community pharmacies be offering injectable weight loss drugs? As community pharmacies prepare to start providing the new weight loss drug Wegovy, we take a closer look at whether they are the right setting for people with obesity to access this medicine.…
Weight loss drug semaglutide will ‘soon’ be available to eligible patients, says NICE Trial results showed that participants taking semaglutide lost an average of 12% more of their body weight compared with placebo.…
